These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 16120141)
1. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Harries MJ; Chalmers RJ; Griffiths CE Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141 [TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities. Balasubramaniam P; Stevenson O; Berth-Jones J Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371 [TBL] [Abstract][Full Text] [Related]
3. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study. Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838 [TBL] [Abstract][Full Text] [Related]
4. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244 [TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study. Mrowietz U; Christophers E; Altmeyer P Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands. Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641 [TBL] [Abstract][Full Text] [Related]
7. Proteinuria with fumaric acid ester treatment for psoriasis. Ogilvie S; Lewis Jones S; Dawe R; Foerster J Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009 [TBL] [Abstract][Full Text] [Related]
8. Fumaric acid esters for psoriasis: a systematic review. Smith D Ir J Med Sci; 2017 Feb; 186(1):161-177. PubMed ID: 27271164 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions. Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fumaric acid esters in combination with phototherapy in patients with moderate-to-severe plaque psoriasis (FAST). Weisenseel P; Reich K; Griemberg W; Merten K; Gröschel C; Gomez NN; Taipale K; Bräu B; Zschocke I J Dtsch Dermatol Ges; 2017 Feb; 15(2):180-186. PubMed ID: 28214304 [TBL] [Abstract][Full Text] [Related]
11. Fumaric acid ester-induced T-cell lymphopenia in the real-life treatment of psoriasis. Dickel H; Bruckner T; Höxtermann S; Dickel B; Trinder E; Altmeyer P J Eur Acad Dermatol Venereol; 2019 May; 33(5):893-905. PubMed ID: 30680823 [TBL] [Abstract][Full Text] [Related]
12. Fumaric acid esters in combination with a 6-week course of narrowband ultraviolet B provides an accelerated response compared with fumaric acid esters monotherapy in patients with moderate-to-severe plaque psoriasis: a randomized prospective clinical study. Tzaneva S; Geroldinger A; Trattner H; Tanew A Br J Dermatol; 2018 Mar; 178(3):682-688. PubMed ID: 29114862 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions - a retrospective evaluation (FACTS). Thaçi D; Weisenseel P; Philipp S; Rosenbach T; Rotterdam S; Augustin M; Neureither M; Reich K J Dtsch Dermatol Ges; 2013 May; 11(5):429-35. PubMed ID: 23433431 [TBL] [Abstract][Full Text] [Related]